Abraham Hochberg

Jerusalem, JM 91904, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

When cancer meets quantum mechanics.

When cancer meets quantum mechanics.

Journal: Theoretical biology forum

Published: January 01, 2019

The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.

The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.

Journal: Molecular cancer

Published: June 23, 2015

The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer.

The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer.

Journal: Journal of translational medicine

Published: November 30, 2014

DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer.

DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer.

Journal: The Journal of urology

Published: December 06, 2013

Oncofetal H19 RNA promotes tumor metastasis.

Oncofetal H19 RNA promotes tumor metastasis.

Journal: Biochimica et biophysica acta

Published: November 06, 2013

NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.

NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 21, 2013

The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention.

The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention.

Journal: International journal of molecular sciences

Published: December 03, 2012

Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Journal: International journal of clinical and experimental medicine

Published: October 29, 2012

Use of preclinical models to assess the therapeutic potential of new drug candidates for bladder cancer.

Use of preclinical models to assess the therapeutic potential of new drug candidates for bladder cancer.

Journal: Seminars in oncology

Published: October 09, 2012

Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.

Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.

Journal: International journal of clinical and experimental medicine

Published: June 06, 2012

Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.

Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.

Journal: International journal of clinical and experimental medicine

Published: January 09, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026